Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials

Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials

Item
http://www.wikidata.org/entity/Q34693351
Developments in managing severe chronic pain: role of oxycodone-naloxone extended releaseEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionDevelopment of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioidsRandomized open-label phase II study comparing oxycodone-naloxone with oxycodone in early return of gastrointestinal function after laparoscopic colorectal surgery.Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-AnalysisIs oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report.Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice.Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation.Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study.
P2860

Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials

Item
http://www.wikidata.org/entity/Q34693351
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Long-term evaluation of combin ...... phases of two Phase III trials
@ast
Long-term evaluation of combin ...... phases of two Phase III trials
@en
Long-term evaluation of combin ...... phases of two Phase III trials
@nl
type
label
Long-term evaluation of combin ...... phases of two Phase III trials
@ast
Long-term evaluation of combin ...... phases of two Phase III trials
@en
Long-term evaluation of combin ...... phases of two Phase III trials
@nl
prefLabel
Long-term evaluation of combin ...... phases of two Phase III trials
@ast
Long-term evaluation of combin ...... phases of two Phase III trials
@en
Long-term evaluation of combin ...... phases of two Phase III trials
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Long-term evaluation of combin ...... phases of two Phase III trials
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932